← Back to Search

Dietary Supplement

Stem Cell Support Formula for Osteoarthritis

N/A

Waitlist Available

Led By Christopher Centeno, MD

Research Sponsored by Regenexx, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months

Awards & highlights

Study Summary

This trial is testing a joint supplement to see if it helps improve joint function in patients with knee OA.

Eligible Conditions

Osteoarthritis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Minimal Clinically Important Difference (MCID) for LEFS

Secondary outcome measures

Additional medications or treatments

Adverse events

International Knee Documentation Committee (IKDC) Subjective Knee Evaluation change from baseline

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Supplement formulaExperimental Treatment1 Intervention

Patients randomized to the experimental group will receive daily 1-ounce doses of stem cell support formula for 60 days. Patients will complete patient-reported outcome questionnaires at 1 month and 2 months.

Group II: Placebo formulaPlacebo Group1 Intervention

Patients randomized to the control group will receive a daily 1-ounce doses of placebo stem cell support formula for 60 days. Patients will complete patient-reported outcome questionnaires at 1 month and 2 months.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Stem Cell Support Formula

2021

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Regenexx, LLCLead Sponsor

14 Previous Clinical Trials

50,765 Total Patients Enrolled

4 Trials studying Osteoarthritis

125 Patients Enrolled for Osteoarthritis

Christopher Centeno, MDPrincipal InvestigatorRegenexx, LLC and Centeno-Schultz Clinic

12 Previous Clinical Trials

50,317 Total Patients Enrolled

3 Trials studying Osteoarthritis

77 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this medical trial?

"According to clinicaltrials.gov, this trial is in its recruitment phase. The investigation was initiated on 2/3/2021 and the information has been recently modified as of 3/4/2022."

Answered by AI

Is there an age limit for the participants in this clinical experiment?

"Based on the requirements for enrolment, this trial only accepts participants aged between 18 and 80."

Answered by AI

May I volunteer for the research project?

"Successful candidates will have a diagnosis of knee osteoarthritis, be aged between 18 and 80, and the trial is currently seeking approximately 80 participants."

Answered by AI

What is the overall sample size of this clinical trial?

"Affirmative. The information on clinicaltrials.gov verifies that this research, which was initially posted on February 3rd 2021, is currently enrolling participants. With the goal of recruiting 80 people from two diverse medical locations."

Answered by AI

Recent research and studies

Stem Cells InternationalJournal

Vitamin C in Stem Cell Biology: Impact on Extracellular Matrix Homeostasis and Epigenetics

D'Aniello, Cristina, Federica Cermola, Eduardo Jorge Patriarca, and Gabriella Minchiotti. 2017. “Vitamin C in Stem Cell Biology: Impact on Extracellular Matrix Homeostasis and Epigenetics”. Stem Cells International. Hindawi Limited. doi:10.1155/2017/8936156.

Scientific ReportsJournal

Curcumin Targets Multiple Enzymes Involved in the ROS Metabolic Pathway to Suppress Tumor Cell Growth

Larasati, Yonika Arum, Noriko Yoneda-Kato, Ikuko Nakamae, Takashi Yokoyama, Edy Meiyanto, and Jun-ya Kato. 2018. “Curcumin Targets Multiple Enzymes Involved in the ROS Metabolic Pathway to Suppress Tumor Cell Growth”. Scientific Reports. Springer Science and Business Media LLC. doi:10.1038/s41598-018-20179-6.

Plos OneJournal

Glucosamine Downregulates the Il-1β-induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-glcnac Modification-dependent and -independent Mechanisms

Someya, Akimasa, Takako Ikegami, Koji Sakamoto, and Isao Nagaoka. 2016. “Glucosamine Downregulates the Il-1β-induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-glcnac Modification-dependent and -independent Mechanisms”. Edited by Francisco J. Esteban. Plos One. Public Library of Science (PLoS). doi:10.1371/journal.pone.0165158.

Life SciencesJournal